Single Ascending Oral Dose Study of F901318

Clinical trial NCT02394483 · COMPLETED

Trial details

NCT number: NCT02394483
Sponsor: F2G Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Invasive Aspergillosis

Start date: 2015-10-01
Primary completion: 2016-09-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.